1ST 106
Alternative Names: 1ST-106Latest Information Update: 16 Jan 2025
Price :
$50 *
At a glance
- Originator 1St Biotherapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurodegenerative disorders
Most Recent Events
- 09 Aug 2024 Early research in Neurodegenerative disorders in South Korea (unspecified route) before August 2024 (1st Biotherapeutics pipeline, August 2024)